echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Infection > Zhejiang Pharmaceutical Vancomycin Hydrochloride for Injection Passed the Consistency Evaluation of Generic Drugs

    Zhejiang Pharmaceutical Vancomycin Hydrochloride for Injection Passed the Consistency Evaluation of Generic Drugs

    • Last Update: 2021-06-22
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    On June 15, Zhejiang Medicine announced that it had recently received a "Drug Supplementary Application Approval Notice" of 0.


    Vancomycin is a narrow-spectrum glycopeptide antibiotic produced by a strain of Streptomyces orientalis


    Bacteria effective for methicillin-resistant Staphylococcus aureus and other bacterial infections caused by: sepsis, a sense of infectious endocarditis, osteomyelitis, arthritis, burns, surgical trauma and other superficial secondary infections, pneumonia , lung abscess, empyema, peritonitis, meningitis


    At present, Zhejiang Medicine has invested about 6 million yuan in research and development expenses for the evaluation of the consistency of vancomycin hydrochloride for injection .
    The company's 2020 sales revenue of vancomycin hydrochloride for injection is 193,354,400 yuan .


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Related Articles

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.